Literature DB >> 15805603

Favourable mediation of crystal contacts by cocoamidopropylbetaine (CAPB).

Suat Ozbek1, Jürgen F Müller, Egbert Figgemeier, Jörg Stetefeld.   

Abstract

Crystals of excellent quality are a prerequisite for high-resolution X-ray data. However, in refinement protocols of crystallization conditions it is often difficult to obtain the right combination of, for example, protein concentration, drop size, temperature and additives. A novel approach for optimizing crystal contacts in a most favourable fashion by performing crystallization setups with the zwitterionic surfactant cocoamidoproylbetaine (CAPB) is introduced. In the presence of this surfactant, highly diffracting crystals were obtained. Here, data from a right-handed coiled coil (RHCC) in complex with CAPB at 1.4 A resolution are presented. The addition of CAPB using otherwise identical crystallization conditions and the same X-ray source caused an improvement in resolution from 2.9 to 1.4 A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805603     DOI: 10.1107/S0907444905001204

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

1.  An interdomain disulfide bridge links the NtA and first FS domain in agrin.

Authors:  Ainsley A McFarlane; Jörg Stetefeld
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

2.  Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively.

Authors:  Johannes A Eble; Matthew McDougall; George L Orriss; Stephan Niland; Benjamin Johanningmeier; Gottfried Pohlentz; Markus Meier; Simone Karrasch; Maria Inacia Estevão-Costa; Augusto Martins Lima; Jörg Stetefeld
Journal:  PLoS Biol       Date:  2017-07-13       Impact factor: 8.029

3.  Predicting substitutions to modulate disorder and stability in coiled-coils.

Authors:  Yasaman Karami; Paul Saighi; Rémy Vanderhaegen; Denis Gerlier; Sonia Longhi; Elodie Laine; Alessandra Carbone
Journal:  BMC Bioinformatics       Date:  2020-12-21       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.